All News | Regulatory

CONTROLLED SUBSTANCES NEWS

Aug 21, 2014
To Tighten Controls, DEA Moves Hydrocodone Combination Products to Schedule II
Aug 19, 2014
N.J. Pharmacist Charged in Scheme to Distribute Oxycodone
Aug 1, 2014
Staten Island Doctor Loses New York Medical License, DEA Registration
Jul 31, 2014
California Physician’s Registration Revoked Following Loss of Medical License
Jul 24, 2014
New Abuse-Deterrent Extended-Release Oxycodone Approved by FDA
Jul 22, 2014
Keys to Denial of Registration: Owner's Lack of Experience, Noncompliance
Jul 21, 2014
California Health System to Pay $1.55M and Implement Action Plan to Resolve Alleged CSA Violations
Jul 21, 2014
FedEx Indicted for Alleged Role in Distributing Drugs for Illegal Internet Pharmacies
Jul 9, 2014
CVS Caremark Halts Sales of Single-Ingredient Pseudoephedrine in West Virginia
Jul 2, 2014
Proposed 2015 Production Quotas Published by DEA
Jul 2, 2014
Opioid Analgesic Tramadol to Be Controlled in Schedule IV
Jul 1, 2014
CDC Calls on States to Monitor, Stop Overprescribing of Opioids; South Shows Highest Rates
Jun 27, 2014
Oxycodone Wholesaler’s Poor Sales Practices Draw $4 Million Civil Penalty
Jun 20, 2014
New York Medical Marijuana Legislation Nears Passage
Jun 13, 2014
Proposed Adjustments to 2014 Production Quotas
Jun 11, 2014
Bills to Amend CSA Would Speed Scheduling Process for Some Drugs, Provide New Rights to Registrants
Jun 9, 2014
Actions to Revoke, Deny, Suspend Registrations to Handle Controlled Substances and List I Chemicals
Jun 5, 2014
DEA Sets Quotas for Designer Drugs; Synthetic Cathinones Latest Addition
May 30, 2014
Historic House Vote Would Bar Federal Interference in State Medical Marijuana Programs
May 23, 2014
Owner of Ohio Pain Clinics Must Forfeit $6.3 Million, Serve 14 Years; Six Doctors Implicated
May 8, 2014
DEA Makes Adjustment to 2014 Marijuana Quota
May 8, 2014
Deterrent Effect on Others May Be Considered in Revoking Individual Registration, Ruling Says
May 2, 2014
Florida Physician Allowed to Retain Registration With Conditions, After Owning Up to Violations
Apr 28, 2014
2014 Quotas Set for Newly Controlled Synthetic Cannabinoids
Apr 22, 2014
FDA Commissioner Hamburg Defends Zohydro Approval, Maintains Need for ‘Balance’

Copyright © Thompson Controlled Subtances, a division of CBIS. All rights reserved.